SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.34-9.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (33385)1/15/2010 9:20:07 PM
From: Arthur Radley  Read Replies (1) of 52153
 
Ashley,
As mentioned, I’m non-plussed about Monsanto’s GM seed program as there has to be some effort to address the growing shortage of food, plus, MOS has survived more devastating articles than the one you cite. VF issued this one several years ago, and MOS didn’t miss a beat with their marketing efforts.

vanityfair.com

I would be more concerned about the pending Supreme Court ruling and the related PR that Monsanto put out tonight. The SC ruling will have more of an impact than the Greenpeace funded ‘research’ paper…..IMO!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News